Ditchcarbon
  • Contact
  1. Organizations
  2. Pharmaceutics International, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 24 days ago

Pharmaceutics International, Inc.

Company website

Pharmaceutics International, Inc. (PII), headquartered in the United States, is a leading player in the pharmaceutical contract development and manufacturing industry. Founded in 1997, the company has established a strong presence in key operational regions, including North America and Europe. PII specialises in the formulation and production of complex drug products, particularly in the areas of injectable and oral dosage forms. With a commitment to innovation, Pharmaceutics International offers unique services such as customised formulation development and comprehensive analytical testing. The company has achieved notable milestones, including successful partnerships with major pharmaceutical firms, which solidify its market position as a trusted provider in the industry. PII's dedication to quality and regulatory compliance sets it apart, making it a preferred choice for clients seeking reliable pharmaceutical solutions.

DitchCarbon Score

How does Pharmaceutics International, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

82

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

32

Industry Benchmark

Pharmaceutics International, Inc.'s score of 82 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Pharmaceutics International, Inc.'s reported carbon emissions

Inherited from Jabil Inc.

Pharmaceutics International, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Jabil Inc., which may influence its climate commitments and reporting practices. Pharmaceutics International, Inc. has not established any documented reduction targets or specific climate pledges. However, as part of its corporate family, it may align with the sustainability initiatives and targets set by Jabil Inc. This includes potential commitments to the Science Based Targets initiative (SBTi) and other climate-related frameworks, although specific details regarding these initiatives are not provided. As the company continues to develop its sustainability strategy, it is essential to monitor any future disclosures that may outline its carbon emissions and climate commitments more clearly.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2015201620172018201920202021202220232024
Scope 1
37,100,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
1,182,767,000
0,000,000,000
0,000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
51,478,000
00,000,000
00,000,000
00,000,000
-
-
-
0,000,000,000
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Pharmaceutics International, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Pharmaceutics International, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Pharmaceutics International, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Frontage Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Societal CDMO, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 8 hours ago

Aenova Group GmbH

DE
•
Real estate services (70)
Updated 9 days ago

Patheon BV

US
•
Pharmaceutical Preparation Manufacturing
Updated 25 days ago

Lonza

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Alcami

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251009.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy